Discgenics, Inc.

SALT LAKE CITY, UT · Founded 2007 · CIK 0001503545 · Biotech · Private

Regenerative therapies for spinal degenerative diseases

discgenics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$870K
2 Form D · May 2013
161 months since last filing
Contracts
—
No federal contracts on record
Patents
21
4 granted · 17 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$870,000
Private capital raisedForm D · SEC$3,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1821NEUROPATHIX, INC.—$1.3M
1822CUMBERLAND PHARMACEUTICALS, INC.——
1823Biohaven Environmental Solutions, LLC—$1.4M
1824Discgenics, Inc.—$870K
1825Prairie Pharms, LLC—$455K
1826Magna Pharmaceuticals, Inc.—$1.0M
1827CanaQuest Medical Corp.—$31K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Mark CohenDirector
  • Christopher Duntsch, M.D., Ph.D.Director · Executive Officer
  • J. FlanaganDirector · Executive Officer
  • Kevin FoleyDirector
  • Kevin Foley, M.D.Director · Executive Officer
  • Mike MoffatExecutive Officer
  • Robert WynalekDirector · Executive Officer
  • Greg ZiskindExecutive Officer

Patents

USPTO · 4 granted of 21
  • Human Disc Tissueapplication
  • Human Disc Tissuegranted
  • Capped Syringes And Methods Of Sealing Sameapplication
  • Isolated Discogenic Cells, Methods Of Using, And Methods Of Preparing Same From Mammalian Tissueapplication
  • Isolated Discogenic Cells, Methods Of Using, And Methods Of Preparing Same From Mammalian Tissuegranted
  • Methods And Systems For Treatment Of Intervertebral Disc By Intradiscal Micro-needle Insertionapplication
  • Novel Methods For Production Of Therapeutic Mammalian Cells And Cell Spheres And Compositions Of Sameapplication
  • Methods For The Treatment Of Degenerative Disc Diseasegranted
  • Devices, Methods, And Compositions Useful In Cryo-preservation, -storage, -transport, And Application Of Therapeutic Mammalian Cellsapplication
  • Human Disc Tissuegranted
  • Isolated Discogenic Cells, Methods Of Using, And Methods Of Preparing Same From Mammalian Tissueapplication
  • Isolated Discogenic Cells And Methods Of Preparing Same From Mammalian Tissueapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.